Dr Reddys says Sputnik V in final leg of pilot testing, commercial launch soon
Hyderabad: Dr Reddys Laboratories which has soft-launched Russias COVID-19 vaccine Sputnik V here has expanded the pilot which is in the final leg to other cities such as Mumbai, Bangalore and New Delhi.
Presently it being a limited pilot phase, registration on CoWIN is not open for the public and will become open once the commercial launch is commenced, a press release from Dr Reddy''s said on Wednesday.
The limited pilot soft-launch of the Sputnik V vaccine in India that was initiated by Dr Reddy''s in Hyderabad on May 14 has now been successfully scaled up to other cities such as Visakhapatnam, Bengaluru, Mumbai, Kolkata and Delhi, Baddi, Chennai, Miryalaguda and Kolhapur with more cities to follow in the next few days, Dr Reddy said in an update.
Dr Reddys Laboratories is in a pact with Russian Direct Investment Fund to sell the first 125 million people doses (250 million vials) of Sputnik V in India. The Indian drug-maker recently received nearly three million doses of Sputnik V.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.